A question that comes up across the Energy Lab community, and once sparked a thread here: the cell danger response — Robert Naviaux's idea that cells can get stuck in a defensive, low-energy state long after an infection, toxin, or stress has passed — feels like one of the most plausible explanations for chronic illness, yet clinicians who apply it step by step are strikingly hard to find. So the open question is what building and following a CDR-based healing plan would actually involve for a body living with dysautonomia, sympathetic dominance, metabolic dysfunction, fatigue, and pain.

The short version

The three things worth knowing

The cell danger response is a respected idea, strongest as an explanation of the mechanism. It describes cells flipping into a defensive, low-energy mode after a threat — infection, toxin, physical or emotional stress — and, in chronic illness, staying stuck there instead of finishing the healing cycle. That core biology lines up well with what researchers see in ME/CFS and related conditions. As a lens for understanding the 'why', it is a serious framework — one Energy Lab has cited itself.

There is no validated, step-by-step CDR treatment yet — which is exactly why skilled providers are so hard to find. The gap is real, and it is not a matter of searching harder. The single human test of the treatment idea was one dose of a drug in ten autistic children, and the benefit faded within weeks; nothing comparable has been completed in fatigue-based illness. What is sold as a 'CDR healing plan' is usually other interventions — supplements, elimination diets, detox programs — wearing a CDR label, each with its own thin evidence.

The metabolic logic does point to things that genuinely help steady the state. Pacing and energy management are the best-supported of these; a few mitochondrial-support nutrients are plausible with modest, individual effects. These steady a stuck system rather than 'cure the CDR' — and they protect the two things the unproven programs drain most: money, and energy.

Take the sections in any order; each one stands on its own.

The idea

What the cell danger response actually describes

The cell danger response (CDR) is a framework from Robert Naviaux, a physician-scientist at UC San Diego. The core observation is elegant: when a cell meets a threat of almost any kind — a virus, a toxin, a physical injury, even sustained psychological stress — its mitochondria are the first responders. They shift out of quietly making energy and into defense mode: they change shape and fragment, and they push a molecule called ATP out of the cell, where it acts as a chemical alarm through receptors called purinergic receptors. Neighboring cells hear the alarm and brace too.

Normally this is temporary — the threat clears, an orderly healing sequence switches the alarm off, and the cells go back to ordinary energy-making. The CDR idea is that in chronic illness this healing cycle does not complete: the alarm stays on, cells stay in defensive low-power mode, and a body can feel stuck in a state of emergency long after the original trigger is gone. That picture maps closely onto what many researchers describe in ME/CFS and its cousins — a low-grade viral reactivation keeping the alarm ringing, energy machinery running cold, and the autonomic nervous system knocked off balance as a downstream effect.

The evidence

Three layers, three different answers

The most useful thing to know is that 'is CDR true' is really three questions, and they do not get the same answer. Sorting them apart is what turns a big, foggy topic into something you can actually weigh.

The mechanism — cells switching into mitochondrial defense, releasing ATP as a danger signal, and getting stuck — is reasonably supported. Several independent groups have seen the pieces: fragmented mitochondria, a signal in the blood that can put healthy cells into the same protective mode, a partial reactivation of the HHV-6 virus, and a specific brake on energy metabolism (the pyruvate dehydrogenase step). This layer is the framework's strongest ground.

A specific metabolic test is shakier than it first looks. The anchor study measured hundreds of metabolites in 84 people (45 with ME/CFS, 39 healthy) and found a consistent low-energy 'dauer-like' signature — most markers turned down, a hibernation-like state. But independent groups have found a real yet different fingerprint, the same pattern can appear in other conditions so it does not cleanly single out one disease, and the study was a one-time snapshot, which cannot show cause and effect.

A step-by-step treatment is the thinnest layer of all — thin enough that it is the heart of the answer, and the next section is about it.

Why no one can 'apply it'

The honest reason skilled providers are hard to find

The frustration of not finding a clinician who 'does CDR' is completely understandable — and the reason is not that the right expert is hiding. It is that there is not yet a validated, step-by-step CDR treatment to apply. The much-discussed 'healing cycle' model organizes more than a hundred illnesses into three CDR stages and lists around a hundred receptors that might one day be targeted. That is a research map, a set of hypotheses for the field to test — not a clinical protocol anyone has shown to work.

The one time the treatment idea was tested in people, it was a single intravenous dose of suramin — a century-old sleeping-sickness drug — in ten autistic boys. There was a brief improvement that faded within weeks. Suramin is not approved for this use, is not commercially available for it, and is toxic with repeated dosing, so it is nowhere near a take-home treatment. And crucially, no antipurinergic trial has been completed in ME/CFS, Long COVID, or fibromyalgia at all. So 'I can't find anyone who applies it step by step' is not a personal failing or a gap in effort — it reflects a real, current hole in the science.

A gentle caution

What tends to get sold as a 'CDR healing plan'

Because the label is compelling and the validated protocol is missing, a space has opened up that others fill. What is often marketed as a 'CDR healing plan' or a 'CDR reset' is usually a bundle of familiar interventions — high-dose mitochondrial supplements, restrictive elimination diets, detox or binder regimens, sometimes an expensive multi-phase program — repackaged in cell-danger-response language. Each of those pieces carries its own evidence, and for these purposes it is generally weak or absent. Wrapping them in a respected-sounding theory does not make the bundle proven.

For a body with an energy-limiting condition, the cost here is not only financial. A restrictive diet and an elaborate daily protocol spend the scarcest resource there is — energy — on something unproven, and a flare from over-restriction or over-doing the regimen can set things back. A useful quiet rule: the more confidently a program promises to 'cure the CDR', the further ahead of the actual science it is standing.

A note on judging these programs: an impressive-looking write-up is not the same as evidence. A protocol described in a hundred patients with no comparison group cannot show whether people did better than they would have anyway. The steadier signal is a controlled trial — and for CDR-specific treatment, those do not yet exist.

What actually helps

Where the metabolic logic points that is worth your energy

Here is the reassuring part. Even without a CDR cure, the metabolic way of seeing this illness points toward things that genuinely help — and they sit comfortably inside how Energy Lab already thinks: meet the body at the level of energy and metabolism, and let the nervous system settle as a result rather than forcing it.

Pacing / energy management is the anchor. If the body is stuck in a defensive, low-power state, the single most protective move is to avoid pushing it deeper — staying inside the energy envelope and respecting that the real cost of overdoing it lands 24 to 72 hours later, not in the moment. This is the most evidence-supported approach for energy-limiting conditions, and national guidance now centers it.

Mitochondrial-support nutrients — such as CoQ10 (ubiquinol), NAD+ precursors, and L-carnitine — are biologically plausible and low-risk, with effects that tend to be modest and vary a lot from person to person. They are supportive, not curative, and they belong in the 'gentle, optional' column rather than the 'this is the treatment' column.

Medication questions stay with a clinician. Some doctors do work at the mechanism level in evidence-informed ways — for example targeting viral reactivation or calming neuroinflammation in selected people — but those are individual medical decisions with real trade-offs, made with a personal physician, not something a general framework can prescribe.

The numbers at a glance

The honest map

The cell danger response is a serious, well-cited way of understanding why a body can stay stuck in a defensive, low-energy state long after the original trigger is gone. As an explanation, it has real mechanistic support, and the interest it inspires here is well-founded. As a treatment, it does not yet exist in validated form — no step-by-step CDR protocol has been tested and shown to work, which is precisely why skilled providers who 'apply it' are so hard to find.

That makes the safest use of this framework a quiet one: let it explain the 'why', and let the well-tested basics carry the day-to-day — pacing above all, gentle mitochondrial support where it helps, and every medication decision made with a clinician. The programs that promise a CDR cure are running ahead of the science, and the resource they cost most is the one that is already in shortest supply.

Further reading

1. 1.Naviaux 2014, Mitochondrion - Metabolic features of the cell danger response (the founding framework) - doi.org/10.1016/j.mito.2013.08.006
2. 2.Naviaux et al. 2016, PNAS - Metabolic features of chronic fatigue syndrome (the 'dauer'/hypometabolic signature, n=84) - doi.org/10.1073/pnas.1607571113
3. 3.Germain et al. 2020, Metabolites - independent ME/CFS metabolomics: a real but different fingerprint (n=52) - doi.org/10.3390/metabo10010034
4. 4.Naviaux 2019, Mitochondrion - Metabolic features and regulation of the healing cycle (the CDR-stage model; theory, not a protocol) - doi.org/10.1016/j.mito.2018.08.001
5. 5.Naviaux et al. 2017, Annals of Clinical and Translational Neurology - Low-dose suramin in autism (SAT-1, n=10, single dose, transient) - doi.org/10.1002/acn3.424
6. 6.NICE guideline NG206, 2021 - ME/CFS: diagnosis and management (energy management / pacing) - www.nice.org.uk/guidance/ng206